Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA SUVEN LIFE SCIENCES ASTRAZENECA PHARMA/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 95.5 -20.5 - View Chart
P/BV x 22.7 5.8 391.7% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 ASTRAZENECA PHARMA   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
SUVEN LIFE SCIENCES
Mar-23
ASTRAZENECA PHARMA/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs3,62094 3,860.6%   
Low Rs2,43845 5,416.0%   
Sales per share (Unadj.) Rs401.20.6 64,618.6%  
Earnings per share (Unadj.) Rs39.7-5.4 -732.3%  
Cash flow per share (Unadj.) Rs46.2-5.1 -902.1%  
Dividends per share (Unadj.) Rs16.000-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs234.417.2 1,362.2%  
Shares outstanding (eoy) m25.00218.07 11.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.5111.8 6.8%   
Avg P/E ratio x76.3-12.8 -596.1%  
P/CF ratio (eoy) x65.5-13.5 -483.8%  
Price / Book Value ratio x12.94.0 320.4%  
Dividend payout %40.30-   
Avg Mkt Cap Rs m75,71815,131 500.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2,591186 1,391.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,030135 7,408.0%  
Other income Rs m26184 308.9%   
Total revenues Rs m10,291220 4,680.1%   
Gross profit Rs m1,249-1,196 -104.4%  
Depreciation Rs m16365 248.5%   
Interest Rs m65 117.1%   
Profit before tax Rs m1,341-1,183 -113.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3480-   
Profit after tax Rs m993-1,183 -84.0%  
Gross profit margin %12.5-883.6 -1.4%  
Effective tax rate %26.00-   
Net profit margin %9.9-873.5 -1.1%  
BALANCE SHEET DATA
Current assets Rs m9,3593,455 270.9%   
Current liabilities Rs m4,8441,050 461.2%   
Net working cap to sales %45.01,776.0 2.5%  
Current ratio x1.93.3 58.7%  
Inventory Days Days493,948 1.3%  
Debtors Days Days39218 18.0%  
Net fixed assets Rs m2,0611,373 150.1%   
Share capital Rs m50218 22.9%   
"Free" reserves Rs m5,8113,535 164.4%   
Net worth Rs m5,8613,753 156.2%   
Long term debt Rs m00-   
Total assets Rs m11,4214,828 236.5%  
Interest coverage x213.9-218.8 -97.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90 3,131.7%   
Return on assets %8.7-24.4 -35.9%  
Return on equity %16.9-31.5 -53.8%  
Return on capital %23.0-31.4 -73.3%  
Exports to sales %040.4 0.0%   
Imports to sales %37.4839.8 4.4%   
Exports (fob) Rs mNA55 0.0%   
Imports (cif) Rs m3,7471,137 329.5%   
Fx inflow Rs m61255 1,117.8%   
Fx outflow Rs m3,7471,137 329.5%   
Net fx Rs m-3,135-1,082 289.7%   
CASH FLOW
From Operations Rs m583-1,031 -56.5%  
From Investments Rs m181-2,606 -6.9%  
From Financial Activity Rs m-2453,955 -6.2%  
Net Cashflow Rs m519317 163.5%  

Share Holding

Indian Promoters % 0.0 69.6 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 5.4 0.6 985.5%  
FIIs % 2.7 0.5 492.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 30.4 82.2%  
Shareholders   29,032 74,003 39.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Suven Life Sciences Share Price Performance

Period ASTRAZENECA PHARMA Suven Life Sciences S&P BSE HEALTHCARE
1-Day 0.01% 0.30% 1.18%
1-Month -3.61% -2.06% -0.75%
1-Year 59.20% 114.92% 61.82%
3-Year CAGR 20.50% 14.94% 18.16%
5-Year CAGR 22.18% -16.22% 19.79%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Suven Life Sciences the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.